Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicNASDAQ :CNAT
Date7/2013
Raised$69M
Post IPO Valuation

General Information

Websiteconatuspharma.com
CategoryBioTech
Emailinfo@conatuspharm...
Employees

Offices

San Diego, USA
4365 Executive Drive, Suite 200
San Diego, CA, 92121
USA

People

Co-Founders, President and Chief Executive Officer, Board of Directors
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Senior Vice President, Clinical Research, and Chief Medical Officer
Show All People

Funding

TOTAL $28.5M
FUNDING TOTAL $28.5M
Series B, 2/2011
AgeChem Venture Fund
Aberdare Ventures
Advent Venture Partners
Bay City Capital
Gilde Healthcare Partners
Roche Venture Fund
$20M
Series B, 4/2011
MPM Capital
$7.5M
Venture Round, 6/2013
$1M
DEBT TOTAL $5M
Debt, 10/2010
$5M

Tags

Conatus Pharmaceuticals

Conatus Pharmaceuticals is a privately-held biotechnology company focused on the development of innovative human therapeutics to treat liver disease and cancer. Their lead program, CTS-1027, is currently undergoing Phase 2 clinical trials for the treatment of Hepatitis C Virus (HCV). Conatus licensed CTS-1027 from Hoffmann-La Roche in 2006, and to date its development has been the primary focus of the Company.

Recent Milestones

Videos

Screenshots

Conatus Pharmaceuticals screenshot
Above: Conatus Pharmaceuticals
Uploaded: 2/12/11

Stock Price

Sources

  1. SEC (sec.gov) [edit]
  2. Conatus Pharmaceuticals Completes $20 Million Series B Private Placement Financing (pharmalive.com) [edit]
  3. Conatus Pharmaceuticals Completes the Second Closing of its Series B Private Placement Financing (money.msn.com) [edit]
  4. SEC (sec.gov) [edit]
Edit This Page
Last Edited 12/29/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy